Coronavirus Vaccine Update: After approving two coronavirus vaccines, Pfizer-BioNTech and Moderna, under emergency use authorizations, the US has issued guidelines on allergic reactions to doses, saying to avoid the second dose in case of an allergic response to the former.
Coronavirus vaccine update: a volunteer receives an injection of a coronavirus vaccine (Photo: AP)
The U.S. Centers for Disease Control and Prevention (CDC) issued guidelines on allergic reactions to coronavirus vaccine doses and how people with a history of allergies should proceed with vaccinations. The CDC said that anyone who has had a severe reaction to the first dose of the coronavirus vaccine should not receive the second dose. He defined “severe allergic reaction” as the need for epinephrine medication or treatment in a hospital.
The US CDC said they were monitoring reports of allergic reactions to the coronavirus vaccine. In another guide, the US CDC said that people who have had a severe allergic reaction to any ingredient in a coronavirus vaccine should avoid the vaccine formulation that contains the ingredient.
The United States has so far approved two coronavirus vaccines, Pfizer-BioNTech and Moderna, with emergency use authorizations.
‘CONSULT DOCTORS ABOUT SHOTS OF VACCINES’
The United States said that people who have a history of severe allergic reactions to vaccines should consult their doctors about the coronavirus vaccine. The CDC said that people with severe allergies to food, pets, latex, or environmental conditions, as well as people with allergies to oral medications or a family history of severe allergic reactions, could still get vaccinated.
The country is currently investigating around five allergic reactions That happened after people were given Pfizer’s coronavirus vaccine in the US.
Meanwhile, hours after the US Approved Authorization for Emergency Use of Moderna Coronavirus Vaccine, The latter’s distribution in the United States began on Saturday. More than 3,700 sites would receive and administer vaccines as soon as Monday. The jab developed by Pfizer was licensed on December 11.
CHINA WILL VACCINATE KEY GROUPS FOR THE IMMUNITY OF THE HERD
In order to build a chain of protection for herd immunity through the immunization program, China will first focus on vaccinating high-risk groups during the winter and spring.
the Injections of the coronavirus vaccine will be given first to those who work in cold storage facilities, port quarantine, transportation, fresh food markets, medical workers and those going to study or work abroad, said Zeng Yixin, deputy director of the National Health Commission, during a press conference on virus prevention held at the Office of Information of the Council of State. on Saturday.
